Contemporary optimized practice in the management of pulmonary sarcoidosis

  title={Contemporary optimized practice in the management of pulmonary sarcoidosis},
  author={Shambhu Aryal and Steven D Nathan},
  journal={Therapeutic Advances in Respiratory Disease},
Pulmonary sarcoidosis is the most common form of sarcoidosis, accounting for the initial presentation in over 70% patients and with eventual presence in 90% of patients with sarcoidosis. However, the course of the disease is often unpredictable; its manifestations can be highly variable and its treatment may not be effective in all patients. As such, the optimized treatment of pulmonary sarcoidosis often requires a thoughtful personalized approach with the need to get the patient involved in… Expand
Cardiac sarcoidosis: diagnosis and management.
Current trends in the pathophysiology, diagnosis and management of cardiac sarcoidosis will be reviewed focusing on published research and latest guidelines and a management algorithm is proposed. Expand
Comprehensive Care for Patients with Sarcoidosis
The purpose of this review is to summarize the most recent knowledge regarding different aspects of care and propose a structured approach to sarcoidosis management. Expand
sIL-2R levels predict the spontaneous remission in sarcoidosis.
It is provided useful information that sIL-2R level could be used as a maker for spontaneous remission in determining the treatment strategies for patients with pulmonary sarcoidosis. Expand
Lower Respiratory Tract
  • C. Sergi
  • Medicine
  • Pathology of Childhood and Adolescence
  • 2020
This chapter is completed with more than 400 photographs illustrating several lines of abnormal processes that may be present in a developing lung. Expand
Identification of the Core MicroRNAs and Potential Molecular Mechanismsin Sarcoidosis Using Bioinformatics Analysis
Investigation of the core microRNAs and potential molecular mechanisms in sarcoidosis revealed the dysregulation of hsa-miR-126 and a potential regulatory mechanism for pathogenesis in sarCOidosis. Expand
Recommendations for the management of childhood juvenile idiopathic arthritis‐type chronic anterior uveitis
Australian‐ and New Zealand‐based, uveitis‐specialized ophthalmologists have produced recommendations for the management of juvenile idiopathic arthritis (JIA)‐type chronic anterior uveitis.
It is claimed that £1.3bn has been invested in the construction of this dam in the Czech Republic since its opening in 1991. Expand


Pulmonary function testing and sarcoidosis: A review
PFTs are often performed as part of the initial evaluation of a sarcoidosis patient and can be helpful in phenotyping pulmonary sarcoIDosis as well as evaluating for alternative diagnoses, and increasing evidence that genetics play an important role in the pathogenesis. Expand
The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment
A reflection on when and how immunosuppressive therapies may be helpful for pulmonary sarcoidosis, a consideration of nonpharmacologic management strategies, and a survey of potential novel therapeutic targets for this vexing disease are concluded. Expand
Treatment of sarcoidosis.
For patients with persistent disease, or for patients who are intolerant of systemic steroids, there are several steroid-sparing immune-modulating medications that have been effective for treating sarcoidosis and several immunosuppressives are overviewed. Expand
The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital.
The management issues and guidelines outlined in this paper are based on several longitudinal studies of the sarcoidosis patients summarized here, and 50 years of clinical experience by the senior author at Johns Hopkins Hospital, a tertiary referral center with an active Sarcoid Clinic. Expand
Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes.
Complications of fibrotic pulmonary sarcoidosis include pulmonary hypertension from capillary obliteration and chronic aspergillus disease, with hemoptysis a common and potentially life-threatening manifestation. Expand
Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Advanced sarcoidosis will be the subject of this review with a special focus on pulmonary hypertension and lung transplantation as a last-resort treatment option for some patients with end-stage disease. Expand
Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.
PAH-specific therapy may improve functional class, exercise capacity, and hemodynamics in PH associated with sarcoidosis, and Prospective, controlled trials of PAH therapies for sarCOidosis are warranted to verify this apparent benefit. Expand
Treatment of sarcoidosis.
While glucocorticoids remain the most commonly used agent, other drugs have been used as steroid sparing and for those patients who progress despite routine treatment. Expand
Lung transplantation in sarcoidosis.
  • L. Shah
  • Medicine
  • Seminars in respiratory and critical care medicine
  • 2007
Indications and contraindications to LT among patients with sarcoidosis are reviewed, risk factors for mortality are examined, and optimal timing of referral for LT is discussed. Expand
PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations.
  • G. Akaike, M. Itani, +4 authors F. Behnia
  • Medicine
  • Radiographics : a review publication of the Radiological Society of North America, Inc
  • 2018
FDG PET/CT may be especially useful for assessing reversible granuloma, treatment response, disease extent, occult disease, and cardiac or osseous sarcoidosis, and determining the most suitable biopsy site. Expand